PHAT
Phathom Pharmaceuticals, Inc.
Set alert
5.74 USD -0.48 -7.72%
5.59 Day range 6.32
5.74 52-week range 18.08
- YTD
- -65.40%
- 1 year
- -56.87%
- Open
- 6.32
- Prev close
- 6.22
- Mkt cap
- 466.61M
- Vol
- 1.62M
- Avg vol
- 1.46M
- EPS
- -1.26
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 5.59
- High
- 6.32
- Forward P/E
- 7.60
- Beta
- 0.61
- Short ratio
- 9.36
- Inst. own
- 83.10%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 11.63
- 200-d avg
- 12.45
- 1y target
- 23.70
Financial health
Altman Z-Score
-4.82 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -5.5×
FY 2018 5y median -2.3× FY 2025
P/S 6.9×
FY 2018 5y median 6.9× FY 2025
P/B -2.8×
FY 2018 5y median -2.8× FY 2025
P/FCF -7.3×
FY 2018 5y median -3.4× FY 2025
EV/EBITDA -8.5×
FY 2018 5y median -2.2× FY 2025
EV/Sales 7.4×
FY 2018 5y median 7.4× FY 2025
FCF Yield -13.8%
FY 2018 5y median -29.7% FY 2025
Profitability
Gross Margin 87.1%
FY 2018 5y median 75.5% FY 2025
Operating Margin -91.4%
FY 2018 5y median -91.4% FY 2025
Net Margin -126.3%
FY 2018 5y median -126.3% FY 2025
ROE 50.5%
FY 2018 5y median 131.8% FY 2025
ROIC -125.2%
FY 2018 5y median -94.7% FY 2025
ROA -85.4%
FY 2018 5y median -85.4% FY 2025
Growth (YoY)
Revenue 216.9%
FY 2018 FY 2025
Operating Income 42.3%
FY 2018 FY 2025
EPS (diluted) 42.7%
FY 2018 FY 2025
Free Cash Flow 37.5%
FY 2018 FY 2025
Financial Health
Current Ratio 1.7×
FY 2018 5y median 6.1× FY 2025
Quick Ratio 1.7×
FY 2018 5y median 6.1× FY 2025
Debt / Equity -0.5×
FY 2018 5y median -0.8× FY 2025
Net Debt / EBITDA -0.5×
FY 2018 5y median 0.4× FY 2025
Interest Coverage -2.3×
FY 2018 5y median -4.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31